Frequency of Helicobacter Pylori Seropositivity and C-Reactive Protein Increase in Atrial Fibrillation in Patients Undergoing Coronary Angiography

American Journal of Cardiology

Volumn 101, Issue 6, 2008, Pages 848-851

  Bunch, T Jared ^a   Day, John D ^b,c   Anderson, Jeffrey L ^c,d   Horne, Benjamin D ^c,d   Muhlestein, Joseph B ^c,d   Crandall, Brian G ^b,c   Weiss, J Peter ^b,c   Lappe, Donald L ^b,c   Asirvatham, Samuel J ^a  

^a MAYO CLINIC   (United States)

^b Utah Heart Clinic   (United States)

^c LDS HOSPITAL   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; ANTIBODIES, BACTERIAL; ATRIAL FIBRILLATION; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 40049090246     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.09.118     Document Type: Article

References (19)

1. Anderson J.L., Allen Maycock C.A., Lappe D.L., Crandall B.G., Horne B.D., Bair T.L., Morris S.R., Li Q., and Muhlestein J.B. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol 94 (2004) 1255-1259
2. Gedikli O., Dogan A., Altuntas I., Altinbas A., Ozaydin M., Akturk O., and Acar G. Inflammatory markers according to types of atrial fibrillation. Int J Cardiol 120 (2007) 193-197
3. Ellinor P.T., Low A., Patton K.K., Shea M.A., and MacRae C.A. C-Reactive protein in lone atrial fibrillation. Am J Cardiol 97 (2006) 1346-1350
4. Dernellis J., and Panaretou M. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation. Am J Cardiol 97 (2006) 245-248
5. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., Bauer J.A., Tchou P.J., Niebauer M.J., Natale A., and Van Wagoner D.R. C-Reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
6. Aviles R.J., Martin D.O., Apperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A., Tracy R.P., Van Wagoner D.R., Psaty B.M., Lauer M.S., and Chung M.K. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
7. Roldan V., Marin F., Blann A.D., Garcia A., Marco P., Sogorb F., and Lip G.Y. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 24 (2003) 1373-1380
8. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
9. Saito M., Ishimitsu T., Minami J., Ono H., Ohrui M., and Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 167 (2003) 73-79
10. Suerbaum S., and Michetti P. Helicobacter pylori infection. N Engl J Med 347 (2002) 1175-1186
11. Oshima T., Ozono R., Yano Y., Oishi Y., Teragawa H., Higashi Y., Yoshizumi M., and Kambe M. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 45 (2005) 1219-1222
12. Horne B.D., Muhlestein J.B., Strobel G.G., Carlquist J.F., Bair T.L., and Anderson J.L. Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention. Am Heart J 144 (2002) 491-500
13. Montenero A.S., Mollichelli N., Zumbo F., Antonelli A., Dolci A., Barberis M., Sirolla C., Staine T., Fiocca L., Bruno N., and O'Connor S. Helicobacter pylori and atrial fibrillation: a possible pathogenic link. Heart 91 (2005) 960-961
14. World Health Organization. Initiative for Vaccine Research (IVR). Helicobacter pylori (2007). http://www.who.int/vaccine_research/diseases/soa_bacterial/en/index1.html Accessed September, 2007
15. Franceschi F., Leo D., Fini L., Santoliquido A., Flore R., Tondi P., Roccarina D., Nista E.C., Cazzato A.I., Lupascu A., et al. Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature. Dig Liver Dis 37 (2005) 301-308
16. Moller J.E., Hillis G.S., Oh J.K., Seward J.B., Reeder G.S., Wright R.S., Park S.W., Bailey K.R., and Pellikka P.A. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation 107 (2003) 2207-2212
17. Abhayaratna W.P., Barnes M.E., O'Rourke M.F., Gersh B.J., Seward J.B., Miyasaka Y., Bailey K.R., and Tsang T.S. Relation of arterial stiffness to left ventricular diastolic function and cardiovascular risk prediction in patients > or =65 years of age. Am J Cardiol 98 (2006) 1387-1392
18. Tsang T.S., Barnes M.E., Gersh B.J., Bailey K.R., and Seward J.B. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90 (2002) 1284-1289
19. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., and Singer D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 (2001) 2370-2375